Fig. 5: Explanted devices did not demonstrate evidence of thrombosis.
From: Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes

a The bioreactor in situ at the time of explant, with blood flow demonstrating patency in the arterial and venous grafts and the device. (Note: no DragonSkin silicone shown). b SNM after explant at days 3 or 7 demonstrated no gross thrombi formation. c Scanning electron microscopy (SEM) image of representative SNM surface showed minimal cellular debris after implant into an immunocompetent pig (500Ć magnification) (nā=ā20 SNM from 5 animals).